The Japanese government on March 7 announced new NHI prices for the FY2025 drug price revision, effective April 1. With…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS EPS Gives 400 Workers CDISC Training to Set Itself Apart from Rival CROs
November 28, 2014
-
INTERVIEW Gilead Starting from Scratch to Build Solo Sales Regime: Japan Pres.
November 28, 2014
-
ACADEMIA Avigan’s Efficacy in Ebola “Unknown” with No Corroborative Data: NIID Official
November 27, 2014
-
BUSINESS Kaken Banking on Clenafin to Boost Dermatology Biz
November 27, 2014
-
REGULATORY Debates on Yearly NHI Price Cuts Put on Hold as Attention Turns to Election
November 26, 2014
-
REGULATORY PAFSC First Committee Backs Approval of Takeda’s Vonoprazan
November 25, 2014
-
ORGANIZATION JPMA President Opposes Annual NHI Price Revision
November 21, 2014
-
REGULATORY Chuikyo OKs NHI Price Listing of 14 APIs/15 Products
November 20, 2014
-
REGULATORY 3 Straight Years of NHI Price Cuts Loom as Abe Delays Sales Tax Hike, Eyes Now Turned to 2019 and Beyond
November 19, 2014
-
REGULATORY Health Ministry Drug Evaluation Head Calls for Mulling Necessity of PI Studies for Japanese Patients
November 18, 2014
-
REGULATORY PMDA to Accept All Requests for Generic Drug Face-to-Face Consultations
November 17, 2014
-
BUSINESS Combined Half-Year Sales of Major Japanese Drug Makers Up 2.8% Thanks to Overseas Sales
November 14, 2014
-
REGULATORY New Japan NIH Head Asks Pharma Industry to Suggest Ideas for Benefit of Japanese People
November 13, 2014
-
BUSINESS Generic Makers Back on Growth Track in First Half of FY2014
November 12, 2014
-
BUSINESS Kowa Looks to Triple Eye Drug Business with Glanatec
November 11, 2014
-
BUSINESS Feburic Grabs Top Slot for GP Market in September “Mind Share” Ranking
November 10, 2014
-
BUSINESS Meiji Seika Pharma Poised to Get Lion’s Share in Antidepressant Market
November 10, 2014
-
BUSINESS Sales of Four Major Wholesalers Hit by Drop in Long-Listed Product Sales
November 7, 2014
-
REGULATORY Sept. Drug Price Settlement Rate at 92.6% as Big Hospitals, Pharmacies Take Quantum Leap
November 6, 2014
-
BUSINESS Overseas Growth Boosts Combined Sales of Four Major Drug Makers
November 6, 2014
ページ
Your company’s employer brand is your reputation as an employer and is crucial in attracting top talent. Some reputations are just not good; they may or not be deserved. That is just the perception in the market. Years ago there…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…